Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TLT vs MRNA✓SelectedUSD · MRNATLT vs MRNA performance historyLatest closeAs of+0.16%11/19
Stock and ETF performance explorer

TLT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-14.1%
MRNA return
+806.0%
Excess return
-820.2%
Maximum drawdown
-48.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%+1.3%-1.1%+0.1%
7D+0.8%-13.8%+14.6%+1.0%
30D+0.7%-17.7%+18.4%+0.9%
3M-2.0%+14.3%-16.4%-2.4%
6M-0.9%+336.0%-336.9%-4.3%
YTD-4.2%+575.9%-580.1%-8.2%
1Y-5.3%+724.4%-729.7%-9.6%
3Y+1.5%+160.8%-159.3%-1.8%
5Y-35.0%-24.4%-10.6%-36.5%
All-14.1%+806.0%-820.2%-16.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling